Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Jentadueto

Jentadueto 2.5 mg/850 mg film-coated tablets Jentadueto 2.5 mg/1 000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 9–10

HOS-214091 · Präparat HOS-155256

9 System organ class Frequency of adverse reaction Adverse reaction Infections and infestations Nasopharyngitis uncommon Nausea common Pancreatitis rare # Vomiting uncommon Constipation 2 uncommon Abdominal pain § very common Hepatobiliary disorders Liver function disorders 2 uncommon Hepatitis § very rare Skin and subcutaneous tissue disorders Angioedema rare Urticaria rare Erythema§ very rare Rash uncommon Pruritus uncommon Bullous pemphigoid rare # Investigations Amylase increased uncommon Lipase increased* common * Based on lipase elevations > 3 × ULN observed in clinical trials # Based on Linagliptin cardiovascular and renal safety study (CARMELINA), see also below § Identified adverse reactions of metformin monotherapy. Refer to Summary of Product Characteristics for metformin for additional information † See section 4.4 1 Adverse reaction observed in combination of Jentadueto with sulphonylurea 2 Adverse reaction observed in combination of Jentadueto with insulin

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.